Symbols / COSM $0.35 +0.91%
COSM Chart
About
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Distribution | Market Cap | 13.19M |
| Enterprise Value | 32.37M | Income | -18.54M | Sales | 59.79M |
| Book/sh | 0.73 | Cash/sh | 0.03 | Dividend Yield | — |
| Payout | 0.00% | Employees | 149 | IPO | — |
| P/E | — | Forward P/E | -3.21 | PEG | — |
| P/S | 0.22 | P/B | 0.49 | P/C | — |
| EV/EBITDA | -2.56 | EV/Sales | 0.54 | Quick Ratio | 0.55 |
| Current Ratio | 0.99 | Debt/Eq | 91.08 | LT Debt/Eq | — |
| EPS (ttm) | -0.77 | EPS next Y | -0.11 | EPS Growth | — |
| Revenue Growth | 37.90% | Earnings | 2025-11-14 16:00 | ROA | -13.03% |
| ROE | -63.82% | ROIC | — | Gross Margin | 11.41% |
| Oper. Margin | -10.63% | Profit Margin | -31.01% | Shs Outstand | 37.35M |
| Shs Float | 21.43M | Short Float | 1.11% | Short Ratio | 0.47 |
| Short Interest | — | 52W High | 1.32 | 52W Low | 0.28 |
| Beta | 4.49 | Avg Volume | 803.53K | Volume | 93.42K |
| Target Price | $4.50 | Recom | None | Prev Close | $0.35 |
| Price | $0.35 | Change | 0.91% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$4.50
Mean price target
2. Current target
$0.35
Latest analyst target
3. DCF / Fair value
$-2.56
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.35
Low
$4.50
High
$4.50
Mean
$4.50
- $11.5M Greek pharmacy LOI backs Cosmos Health's $155.8M 2027 goal - Stock Titan ue, 10 Mar 2026 13
- COSM Should I Buy - Intellectia AI Fri, 13 Mar 2026 07
- $COSM stock is up 16% today. Here's what we see in our data. - Quiver Quantitative hu, 15 Jan 2026 08
- Cosmos Health CEO Siokas buys $65,000 in COSM stock - Investing.com hu, 08 Jan 2026 08
- Investors Give Cosmos Health Inc. (NASDAQ:COSM) Shares A 27% Hiding - simplywall.st Sun, 15 Feb 2026 08
- Andreas Bovopoulos reports 9.97% stake in Cosmos Health (NASDAQ: COSM) - Stock Titan ue, 10 Mar 2026 21
- Cosmos Health Inc. CEO Greg Siokas Increases Share Ownership Amid Record Q3 Results - Quiver Quantitative ue, 02 Dec 2025 08
- Cosmos Health stock rises on manufacturing deal with Libytec - Investing.com Mon, 05 Jan 2026 08
- Greek drug distributor adds 100 pharmacies, builds robots for $40M potential - Stock Titan ue, 20 Jan 2026 08
- Insider Stock Purchases: January 13, 2026 | AKTS Stock News - Quiver Quantitative ue, 13 Jan 2026 08
- AI research, crypto and $4.50 call put small-cap Cosmos Health on radar - Stock Titan Wed, 14 Jan 2026 08
- Tesco adds antimicrobial C-Scrub skin wash from Cosmos Health - Stock Titan Wed, 18 Feb 2026 08
- Cosmos Health says its buildings are worth more than its stock - Stock Titan hu, 19 Feb 2026 08
- Why a healthcare group is betting $500,000 on Bitcoin after a sell-off - Stock Titan Wed, 11 Feb 2026 08
- Inside the health company quietly turning higher sales into stronger margins - Stock Titan Fri, 19 Dec 2025 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 388532 | 145000 | — | Purchase at price 0.37 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-02-12 00:00:00 | D |
| 1 | 291262 | 120000 | — | Purchase at price 0.41 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-02-11 00:00:00 | D |
| 2 | 90325 | 45000 | — | Purchase at price 0.50 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-23 00:00:00 | D |
| 3 | 353321 | 175000 | — | Purchase at price 0.50 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-20 00:00:00 | D |
| 4 | 493495 | 220000 | — | Purchase at price 0.45 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-14 00:00:00 | D |
| 5 | 113185 | 57000 | — | Purchase at price 0.50 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-12 00:00:00 | D |
| 6 | 156190 | 81000 | — | Purchase at price 0.52 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-08 00:00:00 | D |
| 7 | 124880 | 65000 | — | Purchase at price 0.52 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-07 00:00:00 | D |
| 8 | 133953 | 72000 | — | Purchase at price 0.54 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2026-01-06 00:00:00 | D |
| 9 | 88314 | 43000 | — | Purchase at price 0.49 per share. | SIOKAS GRIGORIOS | Chief Executive Officer | — | 2025-12-19 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 125.90K | 74.21K |
| TaxRateForCalcs | 0.00 | 0.00 | 0.22 | 0.24 |
| NormalizedEBITDA | -13.51M | -20.62M | -9.47M | -4.13M |
| TotalUnusualItems | -411.04K | 3.56M | 572.26K | 309.19K |
| TotalUnusualItemsExcludingGoodwill | -411.04K | 3.56M | 572.26K | 309.19K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -16.18M | -18.54M | -13.83M | -7.96M |
| ReconciledDepreciation | 1.25M | 614.38K | 188.89K | 449.69K |
| ReconciledCostOfRevenue | 50.12M | 49.03M | 44.39M | 47.91M |
| EBITDA | -13.92M | -17.06M | -8.90M | -3.82M |
| EBIT | -15.17M | -17.68M | -9.09M | -4.27M |
| NetInterestIncome | -605.87K | -203.62K | -3.73M | -3.53M |
| InterestExpense | 1.01M | 866.48K | 3.97M | 3.58M |
| InterestIncome | 406.45K | 662.86K | 236.35K | 46.32K |
| NormalizedIncome | -15.77M | -22.10M | -14.28M | -8.20M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -16.18M | -18.54M | -13.83M | -7.96M |
| TotalExpenses | 69.68M | 75.21M | 57.82M | 60.77M |
| TotalOperatingIncomeAsReported | -15.54M | -21.83M | -7.47M | -4.53M |
| DilutedAverageShares | 19.15M | 11.97M | 1.93M | 656.93K |
| BasicAverageShares | 19.15M | 11.97M | 1.93M | 656.93K |
| DilutedEPS | -1.17 | -2.15 | -33.16 | -23.74 |
| BasicEPS | -1.17 | -2.15 | -33.16 | -23.74 |
| DilutedNIAvailtoComStockholders | -22.38M | -25.78M | -63.95M | -15.59M |
| NetIncomeCommonStockholders | -22.38M | -25.78M | -63.95M | -15.59M |
| OtherunderPreferredStockDividend | 6.20M | 7.24M | 41.55M | 7.63M |
| PreferredStockDividends | 8.56M | |||
| NetIncome | -16.18M | -18.54M | -13.83M | -7.96M |
| NetIncomeIncludingNoncontrollingInterests | -16.18M | -18.54M | -13.83M | -7.96M |
| NetIncomeContinuousOperations | -16.18M | -18.54M | -13.83M | -7.96M |
| TaxProvision | 0.00 | 0.00 | 775.05K | 114.01K |
| PretaxIncome | -16.18M | -18.54M | -13.06M | -7.85M |
| OtherIncomeExpense | -324.30K | 3.49M | -1.85M | 220.31K |
| OtherNonOperatingIncomeExpenses | 86.74K | -65.87K | -2.42M | -88.88K |
| SpecialIncomeCharges | -291.98K | 3.35M | 1.00M | 606.67K |
| OtherSpecialCharges | -1.91M | -1.00M | -606.67K | |
| ImpairmentOfCapitalAssets | 291.98K | 0.00 | ||
| RestructuringAndMergernAcquisition | 0.00 | -1.44M | 0.00 | |
| GainOnSaleOfSecurity | -119.06K | 206.83K | -431.86K | -297.47K |
| NetNonOperatingInterestIncomeExpense | -605.87K | -203.62K | -3.73M | -3.53M |
| InterestExpenseNonOperating | 1.01M | 866.48K | 3.97M | 3.58M |
| InterestIncomeNonOperating | 406.45K | 662.86K | 236.35K | 46.32K |
| OperatingIncome | -15.25M | -21.83M | -7.47M | -4.53M |
| OperatingExpense | 19.56M | 26.18M | 13.43M | 12.86M |
| DepreciationAmortizationDepletionIncomeStatement | 1.25M | 614.38K | 188.89K | 449.69K |
| DepreciationAndAmortizationInIncomeStatement | 1.25M | 614.38K | 188.89K | 449.69K |
| ResearchAndDevelopment | 533.29K | 164.86K | ||
| SellingGeneralAndAdministration | 17.78M | 25.40M | 13.24M | 12.41M |
| SellingAndMarketingExpense | 354.97K | 1.20M | 630.06K | 732.54K |
| GeneralAndAdministrativeExpense | 17.43M | 24.20M | 12.61M | 11.68M |
| OtherGandA | 11.73M | 19.64M | 10.18M | 9.21M |
| SalariesAndWages | 5.69M | 4.55M | 2.43M | 2.47M |
| GrossProfit | 4.31M | 4.35M | 5.96M | 8.33M |
| CostOfRevenue | 50.12M | 49.03M | 44.39M | 47.91M |
| TotalRevenue | 54.43M | 53.38M | 50.35M | 56.24M |
| OperatingRevenue | 54.43M | 53.38M | 50.35M | 56.24M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 86.50K | 86.50K | 15.50K | 15.50K |
| OrdinarySharesNumber | 23.60M | 15.90M | 10.59M | 686.28K |
| ShareIssued | 23.69M | 15.98M | 10.61M | 701.78K |
| NetDebt | 10.80M | 7.43M | 25.78M | |
| TotalDebt | 11.82M | 12.42M | 12.03M | 27.12M |
| TangibleBookValue | 16.78M | 28.24M | 38.58M | 3.89M |
| InvestedCapital | 35.64M | 47.30M | 50.18M | 30.45M |
| WorkingCapital | -296.19K | 12.29M | 34.62M | 9.90M |
| NetTangibleAssets | 16.78M | 28.24M | 38.95M | 3.89M |
| CapitalLeaseObligations | 710.00K | 1.16M | 1.12M | 1.06M |
| CommonStockEquity | 24.53M | 36.04M | 39.28M | 4.38M |
| PreferredStockEquity | 372.41K | |||
| TotalCapitalization | 26.09M | 39.08M | 42.52M | 17.10M |
| TotalEquityGrossMinorityInterest | 24.53M | 36.04M | 39.66M | 4.38M |
| StockholdersEquity | 24.53M | 36.04M | 39.66M | 4.38M |
| OtherEquityInterest | -20.00 | -20.00 | -4.75M | |
| GainsLossesNotAffectingRetainedEarnings | -2.13M | -419.84K | -1.13M | -151.62K |
| OtherEquityAdjustments | -2.13M | -419.84K | -1.13M | -151.62K |
| TreasuryStock | 917.16K | 917.16K | 816.71K | 816.71K |
| RetainedEarnings | -114.02M | -91.64M | -66.23M | -34.35M |
| AdditionalPaidInCapital | 141.58M | 129.01M | 112.21M | 39.69M |
| CapitalStock | 23.69K | 15.98K | 383.02K | 702.00 |
| CommonStock | 23.69K | 15.98K | 10.61K | 702.00 |
| PreferredStock | 0.00 | 0.00 | 372.41K | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 29.78M | 29.97M | 28.38M | 45.05M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 4.02M | 5.65M | 6.63M | 15.12M |
| OtherNonCurrentLiabilities | 1.96M | 1.76M | 2.91M | 1.55M |
| LongTermDebtAndCapitalLeaseObligation | 2.06M | 3.89M | 3.72M | 13.57M |
| LongTermCapitalLeaseObligation | 501.80K | 850.13K | 860.10K | 844.42K |
| LongTermDebt | 1.56M | 3.04M | 2.86M | 12.72M |
| CurrentLiabilities | 25.76M | 24.32M | 21.75M | 29.93M |
| OtherCurrentLiabilities | 3.35M | 3.47M | 2.70M | 1.30M |
| CurrentDebtAndCapitalLeaseObligation | 9.76M | 8.54M | 8.31M | 13.56M |
| CurrentCapitalLeaseObligation | 208.20K | 312.79K | 264.48K | 211.53K |
| CurrentDebt | 9.55M | 8.23M | 8.04M | 13.34M |
| OtherCurrentBorrowings | 2.55M | 1.58M | 2.27M | 8.18M |
| LineOfCredit | 6.99M | 6.63M | 5.76M | 4.70M |
| CurrentNotesPayable | 10.56K | 11.28K | 10.91K | 464.26K |
| PayablesAndAccruedExpenses | 12.65M | 12.31M | 10.74M | 15.07M |
| CurrentAccruedExpenses | 221.82K | 166.35K | 275.55K | 1.02M |
| InterestPayable | 221.82K | 166.35K | 275.55K | 1.02M |
| Payables | 12.43M | 12.14M | 10.47M | 14.05M |
| DuetoRelatedPartiesCurrent | 1.27M | 231.56K | 205.36K | 599.12K |
| TotalTaxPayable | 0.00 | 126.86K | 1.32M | |
| AccountsPayable | 11.16M | 11.91M | 10.13M | 12.13M |
| TotalAssets | 54.31M | 66.01M | 68.04M | 49.43M |
| TotalNonCurrentAssets | 28.85M | 29.41M | 11.67M | 9.60M |
| OtherNonCurrentAssets | 2.92M | 1.06M | 391.62K | 915.25K |
| NonCurrentDeferredAssets | 0.00 | 850.77K | ||
| NonCurrentDeferredTaxesAssets | 0.00 | 850.77K | ||
| NonCurrentNoteReceivables | 5.77M | 7.05M | 7.64M | 4.41M |
| GoodwillAndOtherIntangibleAssets | 7.76M | 7.81M | 706.91K | 485.77K |
| OtherIntangibleAssets | 7.71M | 7.76M | 657.22K | 436.07K |
| Goodwill | 49.70K | 49.70K | 49.70K | 49.70K |
| NetPPE | 12.40M | 13.49M | 2.93M | 2.93M |
| AccumulatedDepreciation | -1.28M | -957.25K | -877.82K | -934.47K |
| GrossPPE | 13.67M | 14.45M | 3.81M | 3.87M |
| Leases | 3.40K | 3.64K | 502.88K | 519.28K |
| ConstructionInProgress | 2.00M | 2.00M | 0.00 | |
| OtherProperties | 709.77K | 1.16M | 1.11M | 1.05M |
| MachineryFurnitureEquipment | 3.11M | 2.95M | 2.19M | 2.30M |
| BuildingsAndImprovements | 4.53M | 4.79M | 0.00 | 834.47K |
| LandAndImprovements | 3.32M | 3.55M | 0.00 | |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 25.46M | 36.61M | 56.37M | 39.83M |
| OtherCurrentAssets | 4.89M | 6.25M | 4.94M | 6.25M |
| PrepaidAssets | 6.26M | |||
| Inventory | 4.36M | 4.79M | 3.45M | 3.15M |
| Receivables | 15.88M | 21.71M | 27.21M | 30.14M |
| DuefromRelatedPartiesCurrent | 1.23M | 1.10M | 2.71M | 3.27M |
| LoansReceivable | 1.17M | 854.34K | 804.96K | 377.59K |
| AccountsReceivable | 13.48M | 19.76M | 23.69M | 26.49M |
| AllowanceForDoubtfulAccountsReceivable | -22.80M | -19.69M | -7.31M | -1.70M |
| GrossAccountsReceivable | 36.28M | 39.45M | 31.00M | 28.19M |
| CashCashEquivalentsAndShortTermInvestments | 336.25K | 3.85M | 20.76M | 297.95K |
| OtherShortTermInvestments | 21.15K | 20.07K | 14.88K | 11.47K |
| CashAndCashEquivalents | 315.11K | 3.83M | 20.75M | 286.49K |
| CashFinancial | 315.11K | 3.83M | 20.75M | 286.49K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -8.98M | -24.80M | -15.25M | -7.99M |
| RepurchaseOfCapitalStock | 0.00 | -100.45K | 0.00 | -376.86K |
| RepaymentOfDebt | -26.28M | -21.27M | -40.39M | -25.66M |
| IssuanceOfDebt | 26.83M | 21.25M | 26.53M | 33.05M |
| IssuanceOfCapitalStock | 649.04K | 10.00M | 41.28M | 250.00K |
| CapitalExpenditure | -1.27M | -9.17M | -383.07K | -890.52K |
| InterestPaidSupplementalData | 704.84K | 406.88K | 588.05K | 2.06M |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 0.00 | 0.00 |
| EndCashPosition | 315.11K | 3.83M | 20.75M | 286.49K |
| BeginningCashPosition | 3.83M | 20.75M | 286.49K | 628.39K |
| EffectOfExchangeRateChanges | -49.47K | -214.14K | 307.04K | 314.31K |
| ChangesInCash | -3.47M | -16.70M | 20.16M | -656.21K |
| FinancingCashFlow | 5.05M | 12.69M | 35.05M | 7.27M |
| CashFlowFromContinuingFinancingActivities | 5.05M | 12.69M | 35.05M | 7.27M |
| NetOtherFinancingCharges | -391.57K | -717.89K | -3.19M | |
| ProceedsFromStockOptionExercised | 4.24M | 3.53M | 10.83M | 0.00 |
| NetPreferredStockIssuance | 0.00 | 6.00M | 0.00 | |
| PreferredStockIssuance | 0.00 | 6.00M | 0.00 | |
| NetCommonStockIssuance | 649.04K | 9.90M | 35.28M | -126.86K |
| CommonStockPayments | 0.00 | -100.45K | 0.00 | -376.86K |
| CommonStockIssuance | 649.04K | 10.00M | 35.28M | 250.00K |
| NetIssuancePaymentsOfDebt | 548.24K | -21.41K | -13.86M | 7.39M |
| NetShortTermDebtIssuance | 809.83K | 660.61K | -1.24M | 8.41M |
| ShortTermDebtPayments | -25.15M | -19.53M | -27.29M | -24.05M |
| ShortTermDebtIssuance | 25.96M | 20.19M | 26.04M | 32.46M |
| NetLongTermDebtIssuance | -261.58K | -682.02K | -12.62M | -1.01M |
| LongTermDebtPayments | -1.13M | -1.74M | -13.10M | -1.60M |
| LongTermDebtIssuance | 865.60K | 1.06M | 487.10K | 591.50K |
| InvestingCashFlow | -798.27K | -13.76M | -21.50K | -826.82K |
| CashFlowFromContinuingInvestingActivities | -798.27K | -13.76M | -21.50K | -826.82K |
| NetOtherInvestingChanges | 468.97K | 638.00K | 351.47K | 63.70K |
| NetInvestmentPurchaseAndSale | 0.00 | -2.63K | 0.00 | |
| PurchaseOfInvestment | 0.00 | -2.63K | 0.00 | |
| NetBusinessPurchaseAndSale | 0.00 | -5.23M | 0.00 | |
| PurchaseOfBusiness | 0.00 | -5.23M | 0.00 | |
| NetIntangiblesPurchaseAndSale | -849.17K | -6.19M | -308.87K | -309.12K |
| PurchaseOfIntangibles | -849.17K | -6.19M | -308.87K | -309.12K |
| NetPPEPurchaseAndSale | -418.07K | -2.98M | -61.47K | -581.40K |
| SaleOfPPE | 0.00 | 12.74K | 0.00 | |
| PurchaseOfPPE | -418.07K | -2.98M | -74.21K | -581.40K |
| OperatingCashFlow | -7.72M | -15.64M | -14.87M | -7.10M |
| CashFlowFromContinuingOperatingActivities | -7.72M | -15.64M | -14.87M | -7.10M |
| ChangeInWorkingCapital | 159.68K | -7.90M | -8.69M | -6.30M |
| ChangeInOtherCurrentLiabilities | 177.96K | -1.96M | 806.81K | 649.54K |
| ChangeInOtherCurrentAssets | 0.00 | 23.29K | ||
| ChangeInPayablesAndAccruedExpense | 1.12M | 472.15K | -285.99K | 4.74M |
| ChangeInAccruedExpense | 69.07K | -115.67K | -913.28K | 292.39K |
| ChangeInInterestPayable | 69.07K | -115.67K | -913.28K | 292.39K |
| ChangeInPayable | 1.05M | 587.81K | 627.29K | 4.45M |
| ChangeInAccountPayable | 1.05M | 716.62K | 1.73M | 3.82M |
| ChangeInTaxPayable | 0.00 | -128.80K | -1.11M | 622.05K |
| ChangeInIncomeTaxPayable | 0.00 | -128.80K | -1.11M | 622.05K |
| ChangeInPrepaidAssets | -2.51M | -1.49M | -1.27M | -3.17M |
| ChangeInInventory | 146.45K | -890.90K | -485.47K | -89.58K |
| ChangeInReceivables | 1.23M | -4.03M | -7.46M | -8.46M |
| ChangesInAccountReceivables | 1.23M | -4.03M | -3.24M | -5.79M |
| OtherNonCashItems | 288.83K | -975.75K | 1.90M | 1.03M |
| StockBasedCompensation | 1.69M | 577.93K | 24.40K | 5.90M |
| UnrealizedGainLossOnInvestmentSecurities | -2.47K | -4.58K | -1.68K | -2.54K |
| AssetImpairmentCharge | 5.09M | 11.85M | 5.62M | 1.30M |
| DeferredTax | -11.84K | 656.98K | 780.10K | -714.11K |
| DeferredIncomeTax | -11.84K | 656.98K | 780.10K | -714.11K |
| DepreciationAmortizationDepletion | 1.25M | 614.38K | 188.89K | 449.69K |
| DepreciationAndAmortization | 1.25M | 614.38K | 188.89K | 449.69K |
| Depreciation | 1.25M | 614.38K | 188.89K | 449.69K |
| OperatingGainsLosses | -1.91M | -856.64K | -800.18K | |
| GainLossOnInvestmentSecurities | -3.38K | 20.26K | -193.51K | |
| NetIncomeFromContinuingOperations | -16.18M | -18.54M | -13.83M | -7.96M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for COSM
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|